Emerging research suggest this peptide, a dual stimulator targeting both GLP-1 and GIP , may offer a significant development for body loss . Preliminary patient trials have indicated impressive reductions in abdominal fat , possibly surpassing current body composition therapies . Nevertheless , more evaluation is necessary to fully assess its lasti